๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatitis B surface antigen monitoring and management of chronic hepatitis B

โœ Scribed by M. J. Sonneveld; R. Zoutendijk; H. L. A. Janssen

Book ID
108886608
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
431 KB
Volume
18
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Association of concurrent hepatitis B su
Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection
โœ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB ๐Ÿ‘ 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (antiโ€HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and antiโ€HBs (concurrent HBsAg/ antiโ€HBs) with hepatocellular carcinoma (HCC). The aim of t

Hepatitis B and D genomes in hepatitis B
Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C
โœ Sara Gonzรกlez; Sonia Navas; Antonio Madejรณn; Javier Bartolomรฉ; Inmaculada Castil ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 607 KB

## Abstract Hepatitis B and hepatitis D viral genomes were tested by nested polymerase chain reaction in the serum and liver of 69 hepatitis B surface antigen (HBsAg) negative, antiโ€hepatitis C virus (HCV) positive patients (47 with HCV RNA and 22 without HCV RNA). Serum hepatitis B virus (HBV) DNA

Hepatitis B virus DNA prediction rules f
Hepatitis B virus DNA prediction rules for hepatitis B e antigenโ€“negative chronic hepatitis B
โœ Jordan J. Feld; Melissa Ayers; Dahlia El-Ashry; Tony Mazzulli; Raymond Tellier; ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 672 KB

After hepatitis B e antigen (HBeAg) seroconversion, hepatitis B may become inactive or progress to HBeAg-negative hepatitis with persistent or intermittent alanine aminotransferase (ALT) elevation. The aim of this study was to prospectively identify factors predictive of the clinical course in HBeAg